SAB Biotherapeutics Inc (SABS) — Defensive Interval Ratio
SAB Biotherapeutics Inc (SABS) has a Defensive Interval Ratio of 3000 days as of June 2026. Defensive assets of $96.21 Million (cash $-, short-term investments $94.36 Million, receivables $1.84 Million) cover 3000 days of daily cash needs of $32.07K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SAB Biotherapeutics Inc Defensive Interval Ratio (2019–2025)
This chart shows how SAB Biotherapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 3000 days, meaning defensive assets of $96.21 Million can fund 3000 days of operations without new revenue. For the complete balance sheet picture, see SAB Biotherapeutics Inc balance sheet assets.
Annual Defensive Interval Ratio for SAB Biotherapeutics Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for SAB Biotherapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See SABS working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2974 days | $87.04 Million | $29.26K/day | $- | $86.09 Million | ▲ +2429 days |
| 2024 | 545 days | $11.92 Million | $21.86K/day | $- | $11.86 Million | ▲ +545 days |
| 2023 | 0 days | $0.00 | $29.63K/day | $- | $0.00 | ▼ -135 days |
| 2022 | 135 days | $5.56 Million | $41.08K/day | $- | $- | ▲ +25 days |
| 2021 | 111 days | $8.01 Million | $72.48K/day | $- | $- | ▼ -568 days |
| 2020 | 679 days | $20.57 Million | $30.31K/day | $- | $- | ▲ +456 days |
| 2019 | 223 days | $2.82 Million | $12.65K/day | $- | $- | — |